European Cardiovascular Disease Symposium

SPLOŠNE INFORMACIJE / GENERAL INFORMATION

The European Atrial Fibrillation Symposium, held in Ljubljana on September 5-6, 2026, is designed for cardiology specialists seeking advanced knowledge in atrial fibrillation management. The programme begins with opening remarks from leading experts, followed by a comprehensive overview of non valvular atrial fibrillation (NVAF). Sessions delve into current NVAF treatment strategies, the latest guideline updates, and approaches to guideline-directed medical therapy. Special focus is given to preventing stroke and systemic embolism in NVAF patients and the role of Rivaroxaban, and management of anticoagulant therapy in NVAF patients with HFrEF.

The event features interactive case discussions, fostering peer-to-peer learning and practical application of evidence-based approaches. Moderators and speakers include renowned professors, ensuring high-level scientific exchange.

The symposium is endorsed and hosted at Ljubljana Castle, with registration open to specialists in cardiology and vascular medicine. Attendees will gain up-to-date insights, practical strategies, and opportunities for expert interaction, enhancing their clinical practice in heart failure care.